Nasdaq
$5.08▲ 1.30%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $210.3MShares out 41.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
24- 9.16After-hours26.09.17 05:254Ownership#●●●
RxSight, Inc.
Insider Eric Weinberg of RxSight, Inc. filed a Form 4 on September 15, 2026, reporting changes in beneficial ownership of securities. This filing provides an official record of the insider's equity transactions.…more
$5.08+1.30%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.10Overnight26.09.10 09:554Ownership
RxSight, Inc.
RxSight, Inc. insider Mark Wilterding filed a Form 4 on September 9, 2026, reporting a change in beneficial ownership of securities as of September 5, 2026. This filing serves as the official record of the executive's equity transaction.…more
$5.08+1.30%vs prev closeView filingShare - 9.10Overnight26.09.10 09:554Ownership
RxSight, Inc.
Director Eric Weinberg of RxSight, Inc. filed a Form 4 to report a change in his beneficial ownership of company securities as of September 5, 2026. This filing serves as a standard disclosure of insider stock transactions.…more
$5.08+1.30%vs prev closeView filingShare
23 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 1d agoClosed26.10.24 09:00#●●●#●●●
RxSight Grants Inducement Equity Awards to New Employees
RxSight has granted stock options and restricted stock units (RSUs) to new employees as a material inducement for their employment. This is a standard corporate practice for talent acquisition and does not represent a material financial event.…more
$5.08+1.30%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 4d agoAfter-hours26.10.21 05:05
●●●●●●●● ●●●●● ●●●●●●
RxSight announced that it will release its financial results for the third quarter of 2026 after the market closes on November 3. Management will host a conference call to discuss the results following the announcement.…more
$5.08+1.30%vs prev close - 6d agoPre-market26.10.19 22:00
●●●●●●●● ●●●●● ●●●●●●
RxSight has appointed new senior leadership, including a Chief Commercial Officer and an EVP of Sales, to strengthen its commercial organization. These hires aim to accelerate the adoption of the company's Light Adjustable Lens technology through improved customer engagement.…more
$5.08+1.30%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report